The nature of cryptic epitopes within the self-antigen myelin basic protein.

Mechanisms that allow potentially autoreactive T cells to escape central tolerance and persist in the peripheral lymphoid organs of healthy individuals are poorly defined. It has been proposed that such cells are specific for epitopes which normally are not well presented to the immune system or, in other words, are cryptic. We have used synthetic peptides to define potential T cell epitopes within the N-terminal portion of myelin basic protein (MBP). These were defined in terms of their relative affinity for the MHC-restriction element I-Au and their ability to activate T cells in mice of the H-2(u) haplotype. Three epitopes were identified, one of which corresponded to the known dominant N-terminal epitope (Ac1-9). The other two epitopes (9-20 and 5-20) bound to their MHC-restriction element with relatively high affinity but were cryptic, as defined by the poor response to these epitopes following immunization with intact MBP. Even the longer of these two epitopes did not induce autoimmune encephalomyelitis in H-2(u) mice. These results demonstrate that antigen processing can control both the induction of and effector function of autoreactive T cells, and is therefore a principal mechanism involved in limiting the autoreactive T cell repertoire.

[1]  H. Mcdevitt,et al.  A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis , 1992, The Journal of experimental medicine.

[2]  E. Unanue,et al.  Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Carayanniotis,et al.  Induction of experimental autoimmune thyroiditis in rats with the synthetic peptide (2495-2511) of thyroglobulin. , 1993, Cellular immunology.

[4]  Lawrence Steinman,et al.  T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.

[5]  D. Wraith,et al.  Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. , 1992, Journal of immunology.

[6]  J. Rothbard,et al.  Interactions between immunogenic peptides and MHC proteins. , 1991, Annual review of immunology.

[7]  S. Pierce,et al.  Peptides of 23 residues or greater are required to stimulate a high affinity class II‐restricted T cell response , 1993, European journal of immunology.

[8]  Lawrence Steinman,et al.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy , 1989, Cell.

[9]  R. Bronson,et al.  Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. , 1995, Journal of immunology.

[10]  J. Berzofsky,et al.  Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. , 1991, Journal of immunology.

[11]  A. Lanzavecchia.  How can cryptic epitopes trigger autoimmunity? , 1995, The Journal of experimental medicine.

[12]  I. Egorov,et al.  Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. , 1985, Journal of immunology.

[13]  D. Wraith,et al.  An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. , 1993, International immunology.

[14]  A. Lanzavecchia,et al.  Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants , 1995, The Journal of experimental medicine.

[15]  K. Mason,et al.  Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH. , 1995, Journal of immunology.

[16]  S. Buus,et al.  Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules , 1994, International immunology.

[17]  L. Bockenstedt,et al.  Self-peptides in the initiation of lupus autoimmunity. , 1995, Journal of immunology.

[18]  Antonio Lanzavecchia,et al.  Irreversible association of peptides with class II MHC molecules in living cells , 1992, Nature.

[19]  D. Wraith,et al.  MHC-binding peptides for immunotherapy of experimental autoimmune disease. , 1992, Journal of autoimmunity.

[20]  D. Kioussis,et al.  Low avidity recognition of self-antigen by T cells permits escape from central tolerance. , 1995, Immunity.

[21]  P. Travers,et al.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. , 1994, Immunology.

[22]  J. Sidney,et al.  High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants. , 1992, International immunology.

[23]  J. Watson.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture , 1979, The Journal of experimental medicine.

[24]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[25]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.